Browse by CSHL Author

[up] Up a level
Group by: Item Type | No Grouping
Jump to: Paper | Conference or Workshop Item
Number of items at this level: 3.

Paper

Cheng, Derek K, Oni, Tobiloba E, Thalappillil, Jennifer S, Park, Youngkyu, Ting, Hsiu-Chi, Alagesan, Brinda, Prasad, Nadia V, Addison, Kenneth, Rivera, Keith D, Pappin, Darryl J, Van Aelst, Linda, Tuveson, David A (May 2021) Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer. Proceedings of the National Academy of Sciences of USA, 118 (21). e2016904118-e2016904118. ISSN 0027-8424

Cheng, D. K., Oni, T. E., Park, Y., Thalappillil, J. S, Ting, H.-C., Alagesan, B., Prasad, N. V., Rivera, K. D., Pappin, D. J., Van Aelst, L., Tuveson, D. A. (September 2020) Oncogenic KRAS engages an RSK1/NF1 complex in pancreatic cancer. BioRxiv. (Unpublished)

Conference or Workshop Item

Ting, Hsiu-Chi, Kim, Sun Y, Gaeth, Victoria, Hinds, Juliene, Deschenes, Astrid, Habowski, Amber N, Smith, Peyton, Yoo, Heesang, Kouassi, Fatim, Jensen, Amanda, Forte, Julia, Portillo, Steven, Kastan, Jonathan, Sodir, Nicole M, Park, Youngkyu, King, Daniel A, Vakoc, Christopher R, Singh, Mallika, Tuveson, David A (2026) FYN antagonizes response to RAS inhibition in pancreatic ductal adenocarcinoma. In: AACR Special Conference in Cancer Research: RAS Oncogenesis and Therapeutics, 2026 Mar 5-8, Los Angeles, CA.

This list was generated on Mon Apr 6 07:01:03 2026 EDT.